Larylin Husten-Stiller

Dropropizine, the active ingredient in Larylin Husten-Stiller, is an antitussive presented as an oral formulation for oral use. It suppresses dry, non‑productive coughs in adults and children by acting on peripheral cough receptors. The medication is available without a prescription across the European Union and is intended for short‑term relief of irritating coughs that do not produce mucus.

GNH USA supplies Larylin Husten‑Stiller as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide. Our distribution network ensures consistent quality and regulatory compliance for each batch delivered.

Dropropizine acts as a peripheral antitussive to reduce the cough reflex in conditions characterized by dry or non‑productive cough.

Dry cough: provides symptomatic relief by decreasing cough frequency and intensity. Non‑productive cough: eases throat irritation without promoting mucus production. Cough due to throat irritation: reduces the urge to cough caused by mild inflammatory stimuli.

Dropropizine is generally well tolerated, but several adverse reactions have been reported.

Common Side Effects: - Nausea: mild stomach upset occurring shortly after ingestion. - Dizziness: transient light‑headedness, especially after the first dose. - Dry mouth: reduced salivation leading to a feeling of throat dryness. - Headache: mild to moderate headache not requiring medical intervention.

Serious or Rare Side Effects: - Allergic skin reactions: rash, urticaria, or itching that may indicate hypersensitivity. - Anaphylactic shock: rare but severe systemic allergic response requiring immediate medical attention.

Before using Larylin Husten-Stiller, consider the following safety measures.

Pregnancy: consult a healthcare professional before use. Breastfeeding: use with caution as safety data are limited. Renal impairment: dose adjustment may be required. Concomitant CNS depressants: monitor for enhanced sedation. Children under 2 years: not recommended unless advised by a physician. Store at below 25°C: keep in the original pack, protect from moisture.

Dropropizine may interact with other substances; review the following categories.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of additive central nervous system depression. - Strong CYP3A4 inhibitors: may increase dropropizine plasma concentrations.

Moderate Interactions (Monitor Closely): - Alcohol: may enhance sedative effects. - Other antitussives: additive cough suppression may lead to excessive suppression. - Antihistamines: may increase dryness of mouth and throat.